* behold page 886 for definitions o...

* behold page 886 for definitions of evidence labels.

As part of a multiphase contrive under contract with the Agency for Healthcare Research and Quality (AHRQ) and a topic nomination through the Centers for Disease have charge of and Prevention, we conducted a systematic review of the literature onward interventions in patients with newly diagnosed epilepsy. Of the 120 studies identified as eligible for inclusion, greatest in quantity qualified as evidence level B with merely 25 percent qualifying as flush A evidence. Thirty-eight of the studies involved children, 38 involved adults, and the remainder included as well-as; not only-but also; not only-but; not alone-but children and adults. Key brew questions and literature findings are instanted in this editorial and are reported in glutted along with methods, in an AHRQ publication. (1)

What expertise, services, and touchstones are required to make the diagnosis of epilepsy and to initiate and monitor optimal treatment?

The literature hints that diagnostic interventions should be tailored to the specific patient population. Different diagnostic approaches may be required in somewhat old patients, young children, and patients with suspected juvenile myoclonic epilepsy, absence seizures, or temporal lobe epilepsy.

The literature supports the value of a careful history, especially in diagnosing juvenile myoclonic epilepsy unless also in obtaining a description (eg focal onset) that is sufficient to determine seizure token The evidence indirectly supports the contribution of a careful neurologic examination (i.e., abnormal neurologic findings after a first seizure predict recurrence) The literature does not provide enough evidence to determine whether vital current tests performed at the time of a first seizure are useful in diagnosing epilepsy and predicting seizure resort although such testing may be useful in ruling on the outside secondary causes of seizures.

Nearly all of the studies we reviewed mentioned the standard electroencephalogram (EEG) as an absolute requirement for the diagnosis of epilepsy. The literature indicates that antiepileptic drugs can mingle confusedly EEG diagnosis of juvenile myoclonic epilepsy. In somewhat advanced in life patients with new-onset epilepsy, magnetic resonance imaging appears to be useful. Ambulatory EEG and video EEG may have a part in the initial diagnosis of epilepsy in real young children, patients with poorly characterized seizure originals and patients with suspected psychogenic seizures.

The literature provides insufficient evidence to determine the cumulative contribution of each ordeal to an accurate diagnosis. There also is not enough evidence to determine the sensitivity and specificity of individual diagnostic tests

What criteria should be used to guide decisions about the timing and selection of treatments for patients with newly diagnosed epilepsy?

Antiepileptic medicines used in the reviewed studies were (in order of decreasing frequency) carbamazepine, valproate, vigabatrin, phenobarbital, oxcarbazepine, phenytoin, gabapentin, lamotrigine, ethosuximide, clonazepam, and primidone. The sign of seizure appeared to be the main determinant of the choice of agent. Studies of comparable patient populations typically showed no differences in the efficacy of anti-epileptic unsalable articles although we performed no formal statistical comparisons.

What interventions are necessary to monitor the first epileptic medicine regimen adequately or to make secure that the diagnosis of epilepsy was correct?

None of the reviewed studies had, as a primary objective, an assessment of monitoring interventions that are necessary for optimal patient care. Thus, necessary and appropriate monitoring remains to be determined according to the treating physician without support from the literature.

What aspects of clinical and pharmacologic expertise have been demonstrated to flow in optimal outcomes in patients with epilepsy?

Although evidence is sparse, the literature glance ats that access to clinical expertise could minimize misdiagnosis and delay in diagnosis. Access to clinical expertise also could improve the choice and timing of initial antiepileptic unsalable article monotherapy. Although remission rates ranging from 35 to 60 percent were reported in most numerous of the antiepileptic drug studies, the highest remission rates (79 to 84 percent) were reported in the studies that busyed clinical or pharmacologic expertise for treatment decisions. (1)

What social services, counseling, and information are necessary for patients at the time of first diagnosis of epilepsy?

No published evidence addressed the social services, counseling, and information that are necessary for patients with newly diagnosed epilepsy.

In the care of patients with epilepsy, "no seizures and no side issues equals control." (2) There are three paces to achieving this goal:

quick and accurate diagnosis of epilepsy in patients presenting with epileptic seizures; administration of an appropriate first treatment intervention; and adequate monitoring to make sure not only the efficacy and safety of the treatment intervention if it be not that also the accuracy of the initial epilepsy diagnosis. Although evidence supporting the best approach to these degrees is limited, physicians should strive to govern epilepsy by using sound clinical long head and applying the best available evidence.